J. Kevin Buchi
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for Sep 17: gift (20,445 AMRX shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade J. Kevin Buchi reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
J. Kevin Buchi's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for J. Kevin Buchi
Use this page
How to cite
Breakaway, J. Kevin Buchi: Director at Amneal Pharmaceuticals (AMRX), Sep 17, 2026, getbreakaway.com/insiders/j-kevin-buchi
Journalists: email support@getbreakaway.com for the data behind this page.